Daniel Vasella - 2009 CEO Pay

Daniel Vasella, Novartis CEO

Daniel Vasella - Novartis

Total Compensation: $17.8 million

Details: In his last year as Novartis' chairman and chief executive, Vasella received a base salary of $2.6 million in 2009, plus short-term incentives of about $99,000, long-term incentives totaling $1.6 million and benefits of about $385,000. He owned 2,924,114 shares in the company. After 14 years as Novartis' CEO, Vasella announced he was stepping down in January. He was replaced by Novartis pharma chief Joe Jimenez (photo).

Novartis News:
Vasella, Jimenez share the limelight
Novartis chief steps aside for Jimenez
New Novartis chief talks productivity
Novartis CEO goes on a 'decluttering' drive
Falling Novartis stock deflates bid for Alcon shares

Daniel Vasella - 2009 CEO Pay
Read more on

Suggested Articles

With a brand new approval for Adakveo under its belt, Novartis Sunday flaunted an analysis showing the drug could cut patient hospitalizations by 40%.

BeiGene only just won its first Brukinsa nod in MCL. But it’s already pushing to join the CLL field, and Sunday it rolled out more data.

How long can one infusion of CAR-T drug Yescarta continue helping patients with refractory large B-cell lymphoma? Pretty long, Gilead showed Saturday.